|
gptkbp:instanceOf
|
biological pathway
|
|
gptkbp:activatedBy
|
synthetic cannabinoids
phytocannabinoids
endogenous cannabinoids
|
|
gptkbp:CB1_receptorLocation
|
central nervous system
|
|
gptkbp:CB2_receptorLocation
|
peripheral nervous system
immune cells
|
|
gptkbp:composedOf
|
gptkb:cannabinoid_receptors
gptkb:endocannabinoids
enzymes
|
|
gptkbp:degradedBy
|
gptkb:fatty_acid_amide_hydrolase
gptkb:monoacylglycerol_lipase
|
|
gptkbp:discoveredIn
|
1990s
|
|
gptkbp:foundIn
|
humans
mammals
vertebrates
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
endocannabinoid system
|
|
gptkbp:influenced
|
homeostasis
fertility
metabolism
sleep
neurotransmitter release
stress response
|
|
gptkbp:mainEndocannabinoids
|
gptkb:2-arachidonoylglycerol
gptkb:anandamide
|
|
gptkbp:mainReceptors
|
gptkb:CB1_receptor
gptkb:CB2_receptor
|
|
gptkbp:modulatedBy
|
gptkb:THC
gptkb:CBD
cannabis
|
|
gptkbp:regulates
|
memory
appetite
immune response
mood
pain sensation
|
|
gptkbp:relatedTo
|
gptkb:nervous_system
immune system
cannabinoid system
|
|
gptkbp:studiedIn
|
gptkb:pharmacy
neuroscience
|
|
gptkbp:target
|
medical research
drug development
|
|
gptkbp:bfsParent
|
gptkb:CBD
|
|
gptkbp:bfsLayer
|
5
|